XML 76 R62.htm IDEA: XBRL DOCUMENT v3.8.0.1
Related Party Transactions (Details Narrative)
12 Months Ended
Dec. 23, 2016
CAD ($)
Dec. 22, 2016
USD ($)
$ / shares
shares
Dec. 31, 2017
USD ($)
shares
Dec. 31, 2016
USD ($)
shares
Dec. 31, 2017
CAD ($)
Accrued consulting fees per month     $ 1,321,336 $ 481,215  
Rent amount     19,500  
Consulting fees     796,336 481,215  
Bonus paid     525,000    
Outstanding balance of consulting fees     0 0  
Payroll expense     $ 296,491 $ 275,913  
Number of common stock issued shares | shares     125,000  
Number of common stock purchase     $ 1,456,492  
Paid to development fee     1,761,935  
Hand MD LLC [Member]          
Outstanding balance of consulting fees     $ 0 0  
Percentage of ownership interest     50.00%   50.00%
Payroll expense     $ 120,000 120,000  
Sneaky Vaunt Corp [Member]          
Royal expense     117,722    
Paid to development fee     761,935    
The Queen Pegasus [Member]          
Royal expense     24,227    
Paid to development fee     1,000,000    
Hand MD Corp [Member]          
Royal expense     125,000    
Minimum royalty payment     250,000    
NomadChoice Pty Limited's [Member]          
Royal expense     380,166 54,881  
Knight Therapeutics Inc [Member]          
Number of common stock issued shares | shares   7,500,000      
Number of common stock purchase   $ 2,000,000      
Distribution gross sale percentage description Knight a distribution fee equal to 30% of gross sales for sales achieved through a direct sales channel and 5% of gross sales for sales achieved through retail sales        
Knight Therapeutics Inc [Member] | CAD [Member]          
Due to related party $ 100,000        
Debt outstanding balance         $ 100,000
Knight Therapeutics Inc [Member] | Minimum [Member]          
Purchase price per share | $ / shares   $ 0.34      
Knight Therapeutics Inc [Member] | Maximum [Member]          
Purchase price per share | $ / shares   $ 0.49      
Knight Therapeutics Inc [Member] | Warrant [Member]          
Cancellation of shares | shares   8,132,002      
Knight Therapeutics Inc [Member] | Stock Option [Member]          
Cancellation of shares | shares   1,000,000      
Warrant exercise price per share | $ / shares   $ 0.25      
Loan Agreement [Member] | Knight Therapeutics Inc [Member]          
Amount owed to related party     559,243 2,752,639  
Loan Agreement [Member] | Knight Therapeutics Inc [Member] | NomadChoice's [Member]          
Amount owed to related party     0 3,680,162  
Loan Agreement [Member] | Knight [Member]          
Amount owed to related party     9,110,030    
Security Agreement [Member] | Knight Therapeutics Inc [Member]          
Amount owed to related party     575,000 625,000  
Royalty Distribution Agreement [Member]          
Royal expense     4,608    
Royalty Distribution Agreement [Member] | Knight Therapeutics Inc [Member]          
Amount owed to related party     39,682 $ 87,678  
Royalty Distribution Agreement [Member] | Knight Therapeutics Inc [Member] | The Queen Pegasus [Member]          
Royal expense     10,274    
Commission Agreement [Member]          
Commissions expense     172,579    
Commission Agreement [Member] | Sneaky Vaunt Corp [Member]          
Commissions expense     2,581    
Commission Agreement [Member] | The Queen Pegasus [Member]          
Amount owed to related party     1,462    
Commission Agreement One [Member]          
Commissions expense     13,952    
Commission Agreement One [Member] | The Queen Pegasus [Member]          
Commissions expense     1,462    
Mr. Jack Ross [Member]          
Accounting fees     12,500    
Rent amount     1,500    
Mr. Jack Ross [Member] | Through April 2017          
Accrued consulting fees per month     41,250    
Mr. Jack Ross [Member] | Through December 2017 [Member]          
Accrued consulting fees per month     57,917    
Ms. Harshbarger [Member] | Consulting Agreement [Member]          
Due to related party     $ 10,000